How to Get GLP-1 in Florida for Weight Loss
The short answer
In Florida, 29.6% of adults have obesity (2024 CDC data), which is lower than the national rate of 33.1%. GLP-1 medications are one option a licensed provider may consider for weight management. Whether Florida Medicaid helps pay for them depends on current state rules, and for most people without coverage, a cash-pay telehealth program is the practical path. Here is the data and what your options look like.
Obesity and metabolic health in Florida
Adults with obesity (2024)
29.6%
Obesity rank of 51 (1 = highest)
#43
No leisure-time physical activity (2024)
25.0%
Adult obesity prevalence in Florida is 29.6%, compared with 33.1% nationally (2024). That places Florida the 9th lowest of the 51 states and DC.
On physical activity, 25.0% of adults in Florida report no leisure-time physical activity, versus 22.5% nationally. Activity level is one of several factors a provider weighs alongside weight history and overall health.
| Measure | Florida | National |
|---|---|---|
| Adult obesity (2024) | 29.6% | 33.1% |
| No leisure-time physical activity (2024) | 25.0% | 22.5% |
Source: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System, 2024 release. Figures reflect self-reported height and weight. Full sources and methodology are listed at the bottom of this page.
Embed this chart on your site (free)
Copy this code. It credits Transformation Health with a link back to this page.
How Florida compares to other states
Florida ranks 43rd of 51 states and DC for adult obesity. See how nearby-ranked states compare:
- Utah obesity and GLP-1 access – 31.0% adult obesity (rank 41)
- Montana obesity and GLP-1 access – 31.0% adult obesity (rank 42)
- New York obesity and GLP-1 access – 29.5% adult obesity (rank 44)
- California obesity and GLP-1 access – 29.1% adult obesity (rank 45)
Or compare every state in one table.
Obesity and GLP-1 access by city in Florida
Statewide averages hide real differences between Florida cities. The CDC’s PLACES project publishes model-based city-level estimates, and we break down the data, plus local telehealth access, for the largest Florida cities:
| City | Adult obesity (2023 estimate) | Adult population |
|---|---|---|
| Kissimmee | 42.2% | 60,486 |
| Pine Hills | 42.2% | 48,711 |
| Poinciana | 41.5% | 52,619 |
| Lakeland | 38.9% | 90,673 |
| St. Cloud | 38.3% | 44,197 |
| Lauderhill | 37.7% | 57,011 |
| Ocala | 37.1% | 49,522 |
| Palm Bay | 36.5% | 94,788 |
| Spring Hill | 36.3% | 90,710 |
| Four Corners | 36.0% | 45,292 |
| Daytona Beach | 35.8% | 61,530 |
| Lehigh Acres | 35.7% | 82,431 |
| Jacksonville | 34.8% | 742,905 |
| Pensacola | 34.7% | 44,583 |
| Orlando | 34.5% | 242,724 |
| Melbourne | 34.5% | 70,277 |
| Deltona | 34.4% | 73,063 |
| Apopka | 34.4% | 40,979 |
| Miami Gardens | 34.3% | 86,101 |
| Bradenton | 34.3% | 45,482 |
| Tallahassee | 34.1% | 161,200 |
| North Miami | 33.7% | 48,169 |
| Sanford | 33.4% | 46,429 |
| Clearwater | 33.3% | 97,848 |
| Fort Myers | 33.0% | 69,361 |
| Port Charlotte | 32.9% | 51,262 |
| St. Petersburg | 32.7% | 216,932 |
| Pinellas Park | 32.5% | 43,759 |
| Largo | 32.2% | 70,816 |
| Town ’n’ Country | 32.0% | 69,150 |
| Tampa | 31.9% | 307,201 |
| Tamarac | 31.6% | 59,804 |
| Sarasota | 31.5% | 47,072 |
| Riverview | 31.4% | 78,756 |
| North Port | 31.4% | 60,318 |
| Pompano Beach | 31.3% | 91,392 |
| Deerfield Beach | 31.3% | 71,517 |
| Homestead | 31.3% | 57,139 |
| Gainesville | 31.2% | 121,188 |
| Brandon | 31.2% | 90,698 |
| Sunrise | 31.2% | 77,900 |
| Port Orange | 31.2% | 51,899 |
| Margate | 31.0% | 47,755 |
| Hialeah | 30.9% | 186,339 |
| Miramar | 30.9% | 102,875 |
| Palm Coast | 30.8% | 73,427 |
| Cape Coral | 30.6% | 157,080 |
| Hollywood | 30.6% | 123,846 |
| Port St. Lucie | 30.5% | 162,085 |
| Alafaya | 30.4% | 70,313 |
| Palm Harbor | 30.4% | 51,254 |
| Fort Lauderdale | 30.3% | 153,220 |
| Wesley Chapel | 30.3% | 47,604 |
| Miami | 29.9% | 369,200 |
| Horizon West | 29.6% | 41,738 |
| West Palm Beach | 29.1% | 95,536 |
| Pembroke Pines | 29.0% | 136,482 |
| Coral Springs | 28.7% | 101,643 |
| Plantation | 28.6% | 73,815 |
| Fountainebleau | 28.5% | 49,705 |
| Coconut Creek | 28.5% | 46,551 |
| Boynton Beach | 28.3% | 66,345 |
| Kendale Lakes | 28.2% | 46,126 |
| Tamiami | 28.2% | 45,436 |
| Davie | 28.0% | 82,973 |
| The Hammocks | 27.9% | 47,612 |
| Westchester | 27.7% | 47,844 |
| Bonita Springs | 27.4% | 47,380 |
| The Villages | 27.0% | 78,764 |
| Delray Beach | 27.0% | 57,823 |
| Miami Beach | 26.7% | 71,432 |
| Doral | 26.5% | 57,349 |
| Kendall | 26.0% | 66,121 |
| Weston | 25.6% | 49,816 |
| Wellington | 24.9% | 47,095 |
| Jupiter | 23.8% | 49,265 |
| Boca Raton | 23.2% | 81,696 |
| Palm Beach Gardens | 22.8% | 50,520 |
City figures are CDC PLACES model-based estimates, sorted highest first. Each city page shows confidence intervals and full methodology.
Does Florida Medicaid cover GLP-1 medications for weight loss?
As of March 2026, Florida Medicaid does not cover GLP-1 medications prescribed for weight loss. The Florida Medicaid preferred drug list (Agency for Health Care Administration, effective April 2026) includes GLP-1 medications only in its diabetes drug classes, and the state’s prior-authorization criteria (revised March 2026) require a type 2 diabetes diagnosis, a recent HbA1c of 6.5% or higher, and a prior trial of metformin. Weight-management GLP-1 formulations do not appear on the preferred drug list. Coverage rules change frequently, vary by plan, and almost always require prior authorization when weight-management GLP-1s are covered at all. Confirm your current benefits directly with Florida Medicaid or your plan administrator before making any decisions.
Nationally, obesity-drug coverage in Medicaid remains limited: only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and several states have narrowed or ended coverage since. Coverage for type 2 diabetes is more common and is separate from weight-management coverage.
GLP-1 telehealth options in Florida
If you do not have coverage, do not qualify under your plan’s criteria, or do not want to navigate prior authorization, a cash-pay telehealth program is one route to discuss. Transformation Health connects patients with independent, licensed providers who evaluate your health history through an online assessment and determine whether a GLP-1 program is medically appropriate. You do not need a diabetes diagnosis to be evaluated, and you do not need insurance.
Pricing is all-inclusive and covers medication, lab work, and provider care with no hidden fees. To see whether you qualify and compare program options, start with the GLP-1 weight loss program overview or check whether you qualify if you are not diabetic.
Compounded semaglutide and tirzepatide in Florida
Most people who start a GLP-1 program in Florida through telehealth receive a compounded medication. Both options are available to Florida residents: compounded semaglutide in an injectable or oral form, and compounded tirzepatide as an injectable. Each is prepared by a US-based, state-licensed compounding pharmacy and requires a prescription from an independent, licensed provider, so there is no separate Florida clinic or pharmacy to visit. Your medication ships to your Florida address after a provider approves the prescription.
Compounded medications are not FDA-approved and are not the same as brand-name versions, so a provider reviews whether one is appropriate for you before anything is prescribed. These guides cover the specifics:
- How to get compounded semaglutide online
- How to get compounded tirzepatide online
- Compounded GLP-1 without insurance, including how cash-pay pricing works
- What compounded semaglutide costs
Who qualifies for GLP-1 weight management in Florida
You do not need a diabetes diagnosis to be considered for GLP-1 weight management. A licensed provider generally evaluates candidates with a body mass index (BMI) of 30 or higher, or 27 or higher when paired with a weight-related health condition such as high blood pressure, elevated cholesterol, or prediabetes. The provider reviews your full health history, current medications, and goals before deciding whether treatment is appropriate, so eligibility is always an individual determination rather than a guarantee.
On age, you must be at least 18 years old to be evaluated in Florida. The upper age limit is 76. A licensed provider makes the final eligibility decision.
A large share of people seeking GLP-1 weight management in Florida are women between roughly 35 and 50 who are navigating weight changes tied to perimenopause, when shifting hormones can make weight harder to manage even when nothing else has changed. If that describes you, the appetite and metabolic effects of GLP-1 medications are one option worth discussing with a provider. You can read more about whether GLP-1 medications are appropriate if you are not diabetic and how GLP-1 medications work.
What an all-inclusive GLP-1 program includes
Out-of-pocket cost is the question most people ask after they learn their plan does not cover weight-management GLP-1s. A transparent telehealth program bundles the pieces into one monthly membership so there are no surprise charges:
- Medication prepared by a US-based, state-licensed compounding pharmacy
- Evaluation and ongoing care from an independent, licensed provider
- Lab work through national labs such as Quest or Labcorp
- Weight-management coaching and check-ins
- Shipping to your door, with no hidden fees and the ability to cancel anytime
Because compounded medications are not FDA-approved and are not the same as FDA-approved generic drugs, a provider will explain what that means for you before anything is prescribed.
How to Get GLP-1 in Florida
The process is built around a medical evaluation, not a checkout. For someone in Florida, it typically looks like this:
- Complete a free online health assessment that covers your history, medications, and goals.
- An independent, licensed provider reviews your information and determines whether a GLP-1 program is medically appropriate. Not everyone qualifies.
- If appropriate, your prescription is sent to a licensed compounding pharmacy and your medication ships to you, with provider support and coaching throughout.
You must be at least 18 years old in Florida to be evaluated. There is no obligation to continue, and the assessment itself is free. If a GLP-1 program is not the right fit for your situation, the provider will tell you. To begin, see the GLP-1 weight loss program overview or compare obesity and access data for other states on the GLP-1 by state page.
See If You Qualify in Under 5 Minutes
Our online assessment is reviewed by a U.S.-licensed physician. No insurance needed. Cancel anytime.
Get StartedData sources and methodology
- Adult obesity and physical inactivity: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. Florida figures are from the 2024 data release; the national comparison is 33.1% (2024). Obesity prevalence is the percentage of adults with a body mass index of 30 or higher, based on self-reported height and weight, so figures may differ from measured surveys such as NHANES. Physical inactivity is the share of adults reporting no leisure-time physical activity (2024).
- Medicaid coverage: KFF, Medicaid Coverage of and Spending on GLP-1s, as of January 2026. Florida-specific status verified against the Florida Medicaid preferred drug list and prior-authorization criteria, the state’s primary source. State Medicaid coverage of GLP-1 medications for weight loss changes frequently and is summarized here for general information only. Always confirm current benefits and prior-authorization rules directly with Florida Medicaid or your plan.
- Data current as of: 2024 CDC release. Page last updated: August 18, 2026.
Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. Medicaid coverage information is general, changes frequently, and should be confirmed with your state program. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.